Covid-19: Export curbs on imported API drugs under review
Posted by
www.biotecnika.org
The commerce and industry ministry is studying a proposal to allow
exports of drugs from active pharmaceutical ingredients (API) which
have been imported under an advance license wherein duty-free imports
are bound to certain export obligations.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/export-curbs-on-imported-api-drugs-under-review/articleshow/74680738.cms
Subscribe to:
Post Comments (Atom)
Post a Comment